FUJI YAKUHIN CO LTD has a total of 70 patent applications. It increased the IP activity by 900.0%. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and foods and drinks are AMAKEM NV, AGENNIX AG and BOMBRUN AGNES.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | China | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | Australia | 5 | |
#5 | Brazil | 5 | |
#6 | Canada | 5 | |
#7 | Mexico | 5 | |
#8 | Argentina | 3 | |
#9 | Hong Kong | 3 | |
#10 | Norway | 3 | |
#11 | Taiwan | 3 | |
#12 | United States | 3 | |
#13 | South Africa | 3 | |
#14 | Hungary | 2 | |
#15 | Israel | 2 | |
#16 | New Zealand | 2 | |
#17 | India | 1 | |
#18 | Republic of Korea | 1 | |
#19 | Malaysia | 1 | |
#20 | Philippines | 1 | |
#21 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Foods and drinks | |
#4 | Medical technology | |
#5 | Chemical engineering | |
#6 | Environmental technology | |
#7 | Thermal processes | |
#8 | Civil engineering |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods | |
#5 | Foods | |
#6 | Air-conditioning | |
#7 | Separation | |
#8 | Climate change adaptation technologies | |
#9 | Hydraulic engineering | |
#10 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Uda Junichiro | 40 |
#2 | Nagata Osamu | 34 |
#3 | Inoue Tsutomu | 28 |
#4 | Sato Takahiro | 23 |
#5 | Kobashi Seiichi | 22 |
#6 | Matsumoto Koji | 21 |
#7 | Ashizawa Naoki | 20 |
#8 | Iwanaga Takashi | 19 |
#9 | Tanaka Ippei | 19 |
#10 | Miyata Sachiho | 19 |
Publication | Filing date | Title |
---|---|---|
BR112019018840A2 | crystalline form and salt of 3- (3,5-dichloro-4-hydroxybenzoyl) -1,1-dioxo-2,3-dihydro-1,3-benzothiazole | |
EP2878598A1 | Crystalline form of 4-[5-(pyridine-4-yl)-1h-1,2,4-triazole-3-yl]pyridine-2-carbonitrile | |
TW200827343A | Novel phenylacetic acid derivative | |
KR20050095317A | Novel 1, 2, 4-triazole compounds | |
TW200404557A | A pharmaceutical composition for preventive and/or therepeutic treatment of constipation and symptom resulting from constipation | |
EP1471065A1 | Novel 1,2,4-triazole compound |